Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor
Joan M. Carboni(Bristol-Myers Squibb (United States)), Tai W. Wong(Bristol-Myers Squibb (United States))
Cited by 203
Related Papers
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy
|Clinical Cancer Research|2010|131